Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvuru Geetha

Showing results (31-40 of 146) with videos related to

Pageof 15
Sort By:
Journal of Community Hospital Internal Medicine Perspectives|December 19, 2018
Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesisQiuyu Jin, Sam Kant, Jihad Alhariri, et al.
Kidney International|January 26, 2016
Crystal-storing histiocytosisShivani Shah, Sanjeev Sethi, Lois Arend, et al.
Clinical Kidney Journal|August 31, 2017
Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitisShivani Shah, Khushleen Jaggi, Keiko Greenberg, et al.
Annals of the Rheumatic Diseases|December 19, 2022
Novel aspects in the pathophysiology and diagnosis of glomerular diseasesAndreas Kronbichler, Ingeborg Bajema, Duvuru Geetha, et al.
Cleveland Clinic Journal of Medicine|May 8, 2018
An unusual complication of peritoneal dialysisMohamad Hanouneh, Pranav Damera, Mehrdad Fetrat, et al.
Cleveland Clinic Journal of Medicine|April 2, 2022
The devil is in the details: Approach to refractory hypokalemiaCarmen Elena Cervantes, Karthik Meiyappan Udayappan, Duvuru Geetha
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplantChristine Murakami, Pradeep Manoharan, Naima Carter-Monroe, et al.
Kidney International Reports|December 20, 2021
Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody VasculitisJyotsna Ghosh, Sam Kant, Isabel Villegas Kastner, et al.
European Journal of Rheumatology|July 28, 2020
Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemicEric J Gapud, Andreas Kronbichler, Philipp Gauckler, et al.
Glomerular Diseases|August 15, 2024
<i>Pneumocystis jirovecii</i> Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance TherapyFaten Aqeel, Michael Joseph Cammarata, Dustin Le, et al.
Pageof 15

Showing results (31-40 of 146) with videos related to

Sort By:
Pageof 15
Journal of Community Hospital Internal Medicine Perspectives|December 19, 2018
Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesisQiuyu Jin, Sam Kant, Jihad Alhariri, et al.
Kidney International|January 26, 2016
Crystal-storing histiocytosisShivani Shah, Sanjeev Sethi, Lois Arend, et al.
Clinical Kidney Journal|August 31, 2017
Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitisShivani Shah, Khushleen Jaggi, Keiko Greenberg, et al.
Annals of the Rheumatic Diseases|December 19, 2022
Novel aspects in the pathophysiology and diagnosis of glomerular diseasesAndreas Kronbichler, Ingeborg Bajema, Duvuru Geetha, et al.
Cleveland Clinic Journal of Medicine|May 8, 2018
An unusual complication of peritoneal dialysisMohamad Hanouneh, Pranav Damera, Mehrdad Fetrat, et al.
Cleveland Clinic Journal of Medicine|April 2, 2022
The devil is in the details: Approach to refractory hypokalemiaCarmen Elena Cervantes, Karthik Meiyappan Udayappan, Duvuru Geetha
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplantChristine Murakami, Pradeep Manoharan, Naima Carter-Monroe, et al.
Kidney International Reports|December 20, 2021
Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody VasculitisJyotsna Ghosh, Sam Kant, Isabel Villegas Kastner, et al.
European Journal of Rheumatology|July 28, 2020
Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemicEric J Gapud, Andreas Kronbichler, Philipp Gauckler, et al.
Glomerular Diseases|August 15, 2024
<i>Pneumocystis jirovecii</i> Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance TherapyFaten Aqeel, Michael Joseph Cammarata, Dustin Le, et al.
Pageof 15